Moore Michael Z, Pérez Carlos A, Hutton George J, Patel Hemali, Cuascut Fernando X
Maxine Mesinger Multiple Sclerosis Center, Baylor College of Medicine, Houston, TX 77030, USA.
Biomedicines. 2023 Apr 20;11(4):1227. doi: 10.3390/biomedicines11041227.
Multiple sclerosis (MS) is an acquired demyelinating disease of the central nervous system (CNS). Historically, research on MS has focused on White persons with MS. This preponderance of representation has important possible implications for minority populations with MS, from developing effective therapeutic agents to understanding the role of unique constellations of social determinants of health. A growing body of literature involving persons of historically underrepresented races and ethnicities in the field of multiple sclerosis is assembling. Our purpose in this narrative review is to highlight two populations in the United States: Black and Hispanic persons with multiple sclerosis. We will review the current understanding about the patterns of disease presentation, genetic considerations, response to treatment, roles of social determinants of health, and healthcare utilization. In addition, we explore future directions of inquiry as well as practical methods of meeting these challenges.
多发性硬化症(MS)是一种获得性中枢神经系统(CNS)脱髓鞘疾病。从历史上看,对MS的研究主要集中在患有MS的白人身上。这种代表性的优势对于患有MS的少数族裔人群可能具有重要影响,从开发有效的治疗药物到理解独特的健康社会决定因素组合所起的作用。越来越多涉及多发性硬化症领域中历史上代表性不足的种族和族裔人群的文献正在汇集。我们撰写这篇叙述性综述的目的是突出美国的两个群体:患有多发性硬化症的黑人和西班牙裔。我们将回顾目前对疾病表现模式、遗传因素、治疗反应、健康社会决定因素的作用以及医疗保健利用情况的理解。此外,我们还探讨了未来的研究方向以及应对这些挑战的实用方法。